福龍馬(603686.SH):控股股東等擬對公司三家科技創新子公司增資
格隆匯5月8日丨福龍馬(603686.SH)公佈,公司控股股東、實際控制人分別與城市服務機器人業務板塊、鋰電業務板塊、龍馬環境科技業務板塊的核心管理團隊通過投資設立員工持股平台分別對全資子公司福龍馬城服機器人科技有限公司、福龍馬新能源科技發展有限公司和控股子公司上海龍馬環境科技有限公司三家科技創新子公司進行增資。
本次放棄優先認繳權事項中,公司控股股東、實際控制人和董事長張桂豐分別擔任增資主體員工持股平台的普通合夥人、執行事務合夥人,本次公司放棄優先認繳權事項構成關聯交易,關聯交易金額4756.40萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.